INOGEN, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
INOGEN, INC. (INGN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $41.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-07
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $41.00K, a 92.56% decline year-over-year.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.33M, a 27.80% decline from fiscal 2024.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.84M, a 3.20% increase from fiscal 2023.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $1.78M, a 691.56% increase from fiscal 2022.
- INOGEN, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $225.00K, a 98.84% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $41.00K 10-Q · filed 2026-08-07 | $41.00K derived: sum of 3 quarters · filed 2026-08-07 | $41.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $41.00K 10-Q · filed 2026-05-08 | $41.00K derived: sum of 2 quarters · filed 2026-05-08 | $41.00K derived: sum of 3 quarters · filed 2026-05-08 | $817.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $776.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.33M 10-K · filed 2026-02-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $776.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.33M 10-Q · filed 2025-11-06 | $1.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $776.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.33M 10-Q · filed 2026-08-07 | $1.60M derived: sum of 3 quarters · filed 2026-08-07 | $1.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $551.00K 10-Q · filed 2026-05-08 | $823.00K derived: sum of 2 quarters · filed 2026-05-08 | $823.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.17M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $272.00K derived: sum of 2 quarters · filed 2026-02-27 | $614.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.84M 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $342.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.57M 10-Q · filed 2025-11-06 | $1.35M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $342.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.57M 10-Q · filed 2025-08-08 | $1.35M derived: sum of 3 quarters · filed 2025-08-08 | $3.08M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-08 | $1.01M derived: sum of 2 quarters · filed 2025-05-08 | $2.74M derived: sum of 3 quarters · filed 2025-05-08 | $2.74M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.52M derived: sum of 2 quarters · filed 2025-02-28 | $1.52M derived: sum of 3 quarters · filed 2025-02-28 | $1.78M 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.73M derived: sum of 2 quarters · filed 2024-11-08 | $2.00M 10-Q · filed 2024-11-08 | $2.00M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $264.00K 10-Q · filed 2024-08-07 | $264.00K derived: sum of 3 quarters · filed 2024-08-07 | $264.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $264.00K 10-Q · filed 2024-05-08 | $264.00K derived: sum of 2 quarters · filed 2024-05-08 | $264.00K derived: sum of 3 quarters · filed 2024-05-08 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $0.00 derived: sum of 2 quarters · filed 2024-03-01 | $225.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $225.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $225.00K 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $77.00K derived: sum of 2 quarters · filed 2023-02-24 | $10.08M derived: sum of 3 quarters · filed 2023-02-24 | $19.42M 10-K · filed 2023-02-24 |
| 2021-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $10.08M derived: sum of 2 quarters · filed 2022-11-03 | $19.42M 10-Q · filed 2022-11-03 | $19.42M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $19.34M 10-Q · filed 2022-08-04 | $19.34M derived: sum of 3 quarters · filed 2022-08-04 | $19.91M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $9.34M 10-Q · filed 2022-05-05 | $9.34M derived: sum of 2 quarters · filed 2022-05-05 | $9.91M derived: sum of 3 quarters · filed 2022-05-05 | $11.77M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $570.00K derived: sum of 2 quarters · filed 2022-02-24 | $2.43M derived: sum of 3 quarters · filed 2022-02-24 | $5.24M 10-K · filed 2022-02-24 |
| 2020-09-30 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.42M derived: sum of 2 quarters · filed 2021-11-04 | $5.23M 10-Q · filed 2021-11-04 | $6.67M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $4.67M 10-Q · filed 2021-08-04 | $6.10M derived: sum of 3 quarters · filed 2021-08-04 | $6.10M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $2.81M 10-Q · filed 2021-05-04 | $4.25M derived: sum of 2 quarters · filed 2021-05-04 | $4.25M derived: sum of 3 quarters · filed 2021-05-04 | $4.25M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.44M derived: sum of 2 quarters · filed 2021-02-24 | $1.44M derived: sum of 3 quarters · filed 2021-02-24 | $7.86M 10-K · filed 2021-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 derived: sum of 2 quarters · filed 2020-11-04 | $6.42M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $6.42M 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $6.42M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |